期刊文献+

阿克拉霉素影响骨髓增生异常综合征细胞株细胞增殖及其机制的初步研究 被引量:3

Effect of aclacinomycin on proliferation of myelodysplastic cell line MUTZ-1 and its mechanism
下载PDF
导出
摘要 目的 探讨阿克拉霉素 ( aclacinomycin,ACM)对骨髓增生异常综合征 ( myelodysplastic syndrome,MDS)细胞株 ( MUTZ- 1)细胞的体外作用及其机制 ,以期为进展期 MDS的治疗提供理论基础。方法 采用 MTT比色法、流式细胞术、DNA凝胶电泳法研究 ACM对 MU TZ- 1细胞生长的影响。结果  ( 1) ACM对 MUTZ- 1细胞的生长具有抑制作用 ,其 4 8小时 IC50 为 0 .4 6μmol。( 2 ) ACM对 MUTZ- 1细胞的作用主要为诱导凋亡。( 3 ) ACM诱导 MUTZ- 1细胞凋亡 ,阻滞细胞于细胞周期的 G2 / M期。结论  ACM可诱导 MDS细胞株细胞凋亡 ,作用靶点位于 G2 / M期。提示诱导细胞凋亡疗法治疗进展期 Objective To explore the effect of aclacinomycin (ACM) on the proliferation of myelodysplastic syndrome (MDS) cell line (MUTZ 1) and its mechanism. Methods MUTZ 1 cell growth was measured by MTT assay, cell apoptosis was investigated by flow cytometry and DNA gel electrophoresis. Results (1)ACM suppressed the growth of MUTZ 1 cells and the IC 50 was 0.46 μmol at 48 h. (2)Inducing apoptosis was the main effect of ACM on MUTZ 1 cells. (3)ACM arrested MUTZ 1 at G2/M phase of cell cycle. Conclusion ACM can induce MDS cell apoptosis and the cell cycle was arrestcd at G2/M phasc which suggests the feasibility of inducing apoptosis in advanced MDS treated by ACM.\;
出处 《实用肿瘤杂志》 CAS 北大核心 2002年第2期88-92,共5页 Journal of Practical Oncology
关键词 阿柔比星 骨髓增生异常综合征 投药 剂量 影响 阿克拉霉素 细胞增殖 aclarubicin/therapeutic use myelodysplastic syndrome/administration and dosage cells,cultured
  • 相关文献

参考文献7

  • 1[1]Steube KG,Gignac SM,Hu ZB,et al.In votro culture studies of childhood myelodysplastic syndrome:Establishment of the cell line MUTZ-1 [J].Leukemia and Lymphomia,1997,25(3-4):345-363.
  • 2[2]Carter BZ,Milella M,Altieri DC,et al.Cytokine-regulated expression of survivin in myeloid leukemia [J].Blood,2001,97(9):2784-2790.
  • 3[3]Bouscary D, Ves JD, Guesnu M, et al. Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes [J].Leukemia,1997,11(6):839-845.
  • 4[4]Parker JE, Mufti GJ. Ineffective haemapoiesis and apoptosis in myelodysplastic syndromes [J].Br J Haematol,1998,101(2):220-230.
  • 5[5]Vermes I,Haanen C,Steffens-Nakken H,et al. A no-vel assay for apoptosis.Flowcytometric detection of phosphatidylserine expression on early apoptosis cells using fluorescein labeled Annexin V [J].J Immunol Methods,1995,184(1):39-51.
  • 6[6]Kroemer G,Petit P,Zamzami N,et al.The biochemistry of apoptosis [J].FASEB J,1995,9(13):1277-1282.
  • 7[7]Sugimoto K,Sasaki M,Tamayose K,et al.Inhibition of p34cdc2 dephosphorylation in DNA damage- and topoisomerase Ⅱ inactivation-induced G2 arrests in HL-60 cells [J].Br J Haematol,1999,105(3):720-729.

同被引文献18

  • 1Steube KG, Gignac SM, Hu ZB, et al. In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ-1. Leuk Lymphoma, 1997; 25:345-363
  • 2Hannun YA. Apoptosis and the dilemma of cancer chemotherapy.Blood, 1997; 89:1845-1853
  • 3Wang CY, Mayo MW, Korueluk RG, et al. NF-kappa B antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 1998; 28: 1680- 1683
  • 4Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome C by direct inhibition of distinct caspases. EMBO J, 1998; 17:2215 - 2223
  • 5Sun C, Cai M, Gunasekera AH, et al. NMR structure and mutagenesis of the inhibitor of apoptosis protein XIAP, Nature, 1999;401: 818 - 822
  • 6Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 2000; 6:1796 - 1803
  • 7Ruemmele FM, Beaulieu JF, O'Connell J, et al. The susceptibility to Fas-induced apoptosis in normal enterocytes is regulated on the level of cIAP-1 and cIAP-2. Biochem Biophys Res Commun, 2002;290: 1308- 1314
  • 8SILVA M,RICHARD C,BENITO A,et al.Expression of Bcl-x in erythroid precursors from patients with polythemia vera[J].N Engl J Med,2008,338(2):564-571.
  • 9Druker BJ? Guilhof F, O,Brien SG,et al. Five-yearfollow-up ofpatient receiving imatinib for chronic myeloid leukemia. N EnglJMed, 2006, 355 (23): 2408-2417.
  • 10叶任髙,陆再英.中医内科学.6版.北京:人民卫生出版社,2005: 610.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部